Colorectal Polyps
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Presence of one or more colorectal polyps, with a diameter of >=1 cm and <2 cm (including sessile, flat, or pedunculated morphologies), as confirmed by colonoscopy. 2.Age between 18 and 80 years, irrespective of gender. 3.Hospitalization at one of the 11 participating research centers and meeting all the eligibility criteria of this study. 4.Voluntary participation and provision of written informed consent.
Exclusion criteria
Exclusion criteria: 1.Current use of anticoagulants (e.g., warfarin, dabigatran, rivaroxaban) or antiplatelet agents (e.g., aspirin, clopidogrel) with a washout period of less than 7 days prior to the procedure. 2.Known history of hematologic diseases (e.g., hemophilia, leukemia) or laboratory-confirmed coagulation disorders. 3.Presence of severe cognitive impairment or psychiatric conditions that would preclude compliance with the endoscopic procedure or post-operative follow-up. 4.Unwillingness to provide written informed consent for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Whether rebleeding has occurred;The time at which rebleeding occurred;Repeat endoscopy for bleeding;Delayed Post-Polypectomy Bleeding; | — |
Secondary
| Measure | Time frame |
|---|---|
| Procedure-Related Perforation Rate;Intraoperative Bleeding; | — |
Countries
China
Contacts
Nanchong Central Hospital